Sanambar Sadighi
Overview
Explore the profile of Sanambar Sadighi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadighi S, Sahinoglu E, Haider Kubba A, Patel J, Hosseini S, Shafiee M, et al.
Asian Pac J Cancer Prev
. 2024 Aug;
25(8):2951-2962.
PMID: 39205594
Objective: To evaluate the iron overload among individuals with acute myeloid leukemia (AML) who have not received red blood cell transfusions. Methods: A comprehensive search was conducted in Embase, PubMed,...
2.
Jahanbani Mazraeh E, Sadighi S, Manifar S, Bakhshandeh H, Rajabi M
Support Care Cancer
. 2023 Jul;
31(8):497.
PMID: 37505326
Purpose: Oral mucositis (OM) is a common complication of cancer treatment that has an impact on a patient's quality of life and the outcome of cancer therapy. This trial evaluated...
3.
Allahyari A, Ehsanpour A, Najafi B, Ansarinejad N, Mehrzad V, Kalantari B, et al.
BMC Cancer
. 2022 Dec;
22(1):1348.
PMID: 36550442
No abstract available.
4.
Allahyari A, Ehsanpour A, Najafi B, Ansarinejad N, Mehrzad V, Kalantari B, et al.
BMC Cancer
. 2022 Sep;
22(1):960.
PMID: 36071409
Background: Breast cancer is the most frequently diagnosed cancer and the leading reason for cancer-related death among women. Neoadjuvant treatment with dual-HER2 (human epidermal growth factor receptor 2) blockade has...
5.
Safari M, Mahjub H, Esmaeili H, Sadighi S
Gastroenterol Hepatol Bed Bench
. 2021 Jul;
14(3):206-214.
PMID: 34221259
Aim: In this study, these methods were used to estimate the treatment effect in patients with gastric cancer in the presence of noncompliance. Background: In medical sciences, simple and advanced...
6.
Sadighi S, Sharifian R, Kazemimanesh M, Muhammadnejad A, Shahosseini Z, Amanpour S, et al.
Iran J Basic Med Sci
. 2021 Jun;
24(4):537-544.
PMID: 34094037
Objectives: Immune checkpoint expression on tumor-infiltrating lymphocytes (TILs) has a correlation with the outcome of neoadjuvant chemotherapy (NAC) in breast cancer. However, the reciprocal effect of these regimens on the...
7.
Behrouzi B, Zokaasadi M, Mohagheghi M, Emami A, Sadighi S
Asian Pac J Cancer Prev
. 2021 Feb;
22(2):611-616.
PMID: 33639681
Background: There are still inconsistencies about the role of metformin on breast cancer. This study was designed to assess metformin's effect on the prognosis of female breast cancer patients with...
8.
Ghadrdan E, Ebrahimpour S, Sadighi S, Chaibakhsh S, Jahangard-Rafsanjani Z
J Oncol Pharm Pract
. 2020 Feb;
26(7):1643-1649.
PMID: 32046578
Introduction: Cisplatin-associated acute kidney injury (AKI) is the major limitation to the use of cisplatin-based chemotherapy regimens. Serum creatinine as a traditional marker did not increase in a timely enough...
9.
Laali E, Fazli J, Sadighi S, Mohammadi M, Gholami K, Jahangard-Rafsanjani Z
J Oncol Pharm Pract
. 2019 Oct;
26(2):428-433.
PMID: 31615347
Introduction: Febrile neutropenia (FN) is one of the dose-limiting adverse effects of chemotherapy. Granulocyte-Colony Stimulating Factors (G-CSFs) minimize the incidence of FN and reduce the risk of neutropenia complications. This...
10.
Alizadeh A, Isanejad A, Sadighi S, Mardani M, Kalaghchi B, Hassan Z
J Cancer Res Clin Oncol
. 2019 Aug;
145(10):2583-2593.
PMID: 31401675
Objective: Exercise training is recently considered as a trend in adjuvant therapies for cancer patients, but its mechanisms need to be scrutinized further. This study is aimed to test the...